StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Operating Cash Flow by Quarter

Operating Cash Flow ($M)

QuarterlyAnnual

Novartis Operating Cash Flow: $5,503M in Q3 2026, down 16.3% from a year earlier.

Latest, Q3 2026
5,503
Period ended Sep 30, 2026
Change on a year earlier
-16.3%
6,571 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Net cash flows from operating activities | 5 503 | 6 571”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Financial statements + Form 6-K (reported directly for each 3-month quarter).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Cash Flow ($M)Year on yearSource
Q3 2026Sep 30, 20265,503-16.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20265,882-11.7%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20263,676+0.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252,264-46.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20256,571+4.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20256,664+36.7%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20253,645+60.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20244,193+64.6%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20246,286+18.5%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20244,875+36.3%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20242,265-20.6%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20232,547-32.4%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20235,304+24.1%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20233,576-4.8%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 20232,852+73.0%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20223,768-3.0%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up operating Cash Flow

Cite this data

StockData. (2026). Novartis Operating Cash Flow ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-operating

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.